Clinical monitoring in
the ICU
Dr. Abhijit Diwate (Associate Professor)
Cardio-Vascular & Respiratory PT
DVVPF College of Physiotherapy,
Ahmednagar 414111
Objectives
 Blood pressure monitoring
 NIBP
 IBP
 Central venous pressure monitoring
 Pulmonary artery pressure monitoring
 Mixed venous oxygen monitoring
 Cardiac output
Why monitor BP?
 Alterations inherent
 Provides data for interpretation/therapeutic
decisions
 Important for determining organ perfusion (MAP
most important, except with the heart)
Noninvasive Hemodynamic Monitoring
 Noninvasive BP
 Heart Rate, pulses
 Mental Status
 Mottling (absent)
 Skin Temperature
 Capillary Refill
 Urine Output
Central Venous
Pressure Monitoring
 CVP measures the filling pressure
of the right ventricular (RV); it
gives an estimate of the
intravascular volume status and is
an interplay of the:
(1) circulating blood volume
(2) venous tone and
(3) right ventricular function.
NORMAL CVP
MEASUREMENTS
 CVP monitoring should normally show
measurements as follows:
 Mid Axilla: 0 - 8 mmHg
 An isolated CVP reading is of limited value;
a trend of readings is much more significant
and should be viewed in conjunction with
other parameters e.g. BP and urine output.
sites
A. Central line from peripheral site (antecubital
fossa commonly selected)
B. Femoral site
C. External jugular site
D. Subclavian site
E. Internal jugular site
 All have their own indications, contraindications,
advantages & disadvantages
Equipment
 Sterile gloves
 Sterile gown and mask (optional)
 Sterile prep solution
 Local anesthetic
 Syringes
 Sterile flush solution
 Suture material (might be included in the kit)
 Dressing material
 Manometer set (this may vary according to whether C.V.P. to be
transduced or not )
 500ml of0.9% Sodium Chloride. (500ml Sodium Chloride with 500
units heparin used in transduced circuits only)
 Pressure bag (only used in transduced circuits)
 Sedatives (if required)
WATER MANOMETER:
 Simple & inexpensive
 Any piece of open IV tubing can be used
 Specific problems include:
 Placement of the catheter in the right ventricle
 TR with a large reflux pressure wave
 Giant ‘a’ waves from the atrium ( cannon waves, A-V
dissociation & nodal rhythms)
Each of these will lead to CVP measurements which
may be misleading, & markedly different from the real
prassure
EQUIPMENT
(a) a sterile bag of fluids
(b) attached fluid administration set
(c) an IV extension set
(d) a manometer and
(e) a stopcock
a.
b.
c.
d.
e.
PRESSURE
TRANSDUCER:
 An electronic system with fast response time &
gives a more accurate wave representation
 This enables maximum & minimum pressures to
be identified as well as visualization of the wave
form which may supply information about the
presence, for example of tricuspid
incompetence
 Further more the mean pressure can be
measured & this is usually the true CVP as it
takes in to account the respiratory cycle
 Disadvantages:
 Complex in setting up the system
 Costly
 Nursing staff need to be familiar with the system
 There is always a risk of electronic problems
(such as ‘baseline drift‘ or mechanical damping
of the system by unnoticed air bubbles in the line
or transducer dome
INFORMATION FROM THE CVP
WAVEFORM
 Besides the actual pressure measurement
there is much information that can be gained
from examining the waveforms
WAVEFORMS IN CVP
consists of three upwards (a, c, & v waves) and two
downward defections (x and y descents).
1. ‘a’ wave → by right atrial contraction and occurs just
after the P wave on the ECG.
2. The ‘c’ wave → due to isovolumic ventricular contraction
forcing the tricuspid valve to bulge upward into the RA
3. The pressure within the RA then decreases as the
tricuspid valve is pulled away from the atrium during
right ventricular ejection, forming the X descent.
4. The RA continues to fill during late ventricular systole,
forming the V wave
5. The Y descent occurs when the tricuspid valve opens
and blood from the RA empties rapidly into the RV
during early diastole
THE CVP WAVEFORM
 Reflects changes in right atrial pressure
during the cardiac cycle
Respiratory variation in CVP
 The respiratory pattern in CVP can be used to
predict fluid responsiveness
 patients who have no inspiratory fall in CVP are
on the flat part of their cardiac function curve
and will not respond to fluids whereas patients
who have an inspiratory fall in CVP are on the
ascending part of the cardiac function curve and
may or may not respond to fluids, depending
how close they start to the plateau
 Patients with an inspiratory fall in CVP are also
more likely to have a fall in cardiac output with
the application of PEEP
Complications of central venous
catheterization
 Complications of central venous cannulation
 Arterial puncture with hematoma
 Arteriovenous fistula
 Hemothorax
 Chylothorax
 Pneumothorax
 Nerve injury Brachial plexus Stellate ganglion (Horner’s syndrome)
 Air emboli
 Catheter or wire shearing
 Complications of catheter presence
 Thrombosis, thromboembolism
 Infection, sepsis, endocarditis
 Arrhythmias
 Hydrothorax
REMOVAL OF CENTRAL LINE
 THIS IS AN ASEPTIC PROCEDURE
 THE PATIENT SHOULD BE SUPINE WITH HEAD
TILTED DOWN
 ENSURE NO DRUGS ARE ATTACHED AND
RUNNING VIA THE CENTRAL LINE
 REMOVE DRESSING
 CUT THE STITCHES
 SLOWLY REMOVE THE CATHETER
 IF THERE IS RESISTENCE THEN CALL FOR
ASSISTANCE
 APPLY DIGITAL PRESSURE WITH GAUZE UNTIL
BLEEDING STOPS
 DRESS WITH GAUZE AND CLEAR DRESSING EG
TEGADERM
PULMONARY ARTERY AND PULMONARY
CAPILLARY WEDGE PRESSURE
MONITORING
 The introduction of pulmonary artery catheter
(PAC) in clinical medicine  one of the most
popular and important advances in monitoring.
 With this catheter:
 PAP, PCWP & CVP can be measured easily
 under most circumstances provides an accurate
estimate of the diastolic filling (preload) of the left
heart
 Cardiac output determination using thermo-dilution
technique is an equally important use of this catheter
Indications For PAP & PCWP
Monitoring
A. Cardiac problems/surgery:
 Poor LV function (EF<0.4; LVEDP> 18 mm Hg)
 Recent MI
 Pts with right heart failure
 Procedures involving CPB
 Complications of MI eg. MR, VSD, ventricular aneurysm.
 Combined lesions eg. CAD+MR or CAD+AS
 Complicated lesions eg. IHSS
 Hemodynamically unstable pts requiring inotropes or IABP counterpulsation
 Major procedures with large fluid shifts and/or blood loss in pts with CAD
B. Non-cardiac situations:
 Shock of any cause or MOF
 Severe pulmonary disease , COPD , PHTN, or PE
 Pts requiring high levels of PEEP
 Bleomycin toxicity
 Complicated surgical procedure
 Massive trauma
 Hepatic transplantation
PA (Swan-Ganz) Catheter description
 The standard 7F thermo-dilution pulmonary
artery catheter consists of a single catheter 110
cm in length containing four lumina.
 It is constructed of flexible, radio-opaque
polyvinyl chloride.
 10 cm increments are marked in black on the
catheter beginning at the distal end.
 At the distal end of the catheter is a latex balloon
of 1.5 cc capacity.
 When inflated, the balloon extends slightly
beyond the tip of the catheter but does not
obstruct it
PULMONARY ARTERY
CATHETER
Types of PA catheters
1.1. The thermo dilution catheter:The thermo dilution catheter:
 is the one described above; using this catheter,
thermo dilution cardiac output & other divided
haemodynamic parameters may be measured
2.2. Pacing:Pacing:
 Some PAC’s have the capacity to provide intra
cardiac pacing
3.3. Mixed venous oxygen saturation:Mixed venous oxygen saturation:
 Special fiber-optic PAC can be used to monitor
mixed venous oxygen saturation SVO2
continuously by the principle of absorption and
reflectance of light through blood
 The normal SVO2 is 75%normal SVO2 is 75% and a 5– 10 %
increase or decrease is considered significant
 A significant decrease in SVO2decrease in SVO2 may be due to:
(a) a decrease in the cardiac output
(b) increase in metabolic rate
(c) decrease in arterial oxygen saturation.
4.4. Ejection fraction catheter :Ejection fraction catheter :
 New-catheters with faster thermistor response times
can be used to determine the right ventricular ejectionright ventricular ejection
fraction in addition to the cardiac outputfraction in addition to the cardiac output
5.5. Continuous cardiac output measurement :Continuous cardiac output measurement :
 Continuous cardiac output measuring PACs contain an
integrated thermal filament at level of the RV
 This filament is activated in a programmed sequence
to provide small amounts of heat, which is then
detected in the PA by a thermistor
 The data by the device yields a rapidly updated, near
continuous value for cardiac output
INVASIVE HEMODYNAMIC
MONITORING
PA Insertion Waves
Components of the Monitoring
System
 Bedside monitor – amplifier is located inside
 The amplifier increases the size of signal
 Transducer – changes the mechanical energy
or pressures of pulse into electrical energy;
should be level with the phlebostatic axis
(intersecting lines from the 4th
ICS,mid axillary
line)
Phlebostatic Axis
Pulmonary Artery Pressure
Monitoring
 Contraindications
 AbsoluteAbsolute
 Tricuspid or Pulmonary valve stenosis
 RA or RV masses
 Tetralogy of Fallot
 RelativeRelative
 Severe arrhythmias
 Coagulopathy
 Newly inserted pacemaker wires
Complications of Swan-Ganz
A. Complications of cannulationComplications of cannulation
 Arterial puncture (carotid, subclavia)
 Haematoma, haemothorax
 Pleural effusion iv) Nerve injury (brachial plexus, stellate
ganglion)
 Emboli (air, catheter insertion)
B. Complications of catheter insertionComplications of catheter insertion
 Cardiac perforation
 Cardiac dysrhythmia , heart block
 Knotting
 Tricuspid, pulmonary valve injury
C. Complications of catheter presenceComplications of catheter presence
 Thrombosis, thromboembolism
 Infection, endocarditis, sepsis
 Pulmonary artery rupture iv) Pulmonary infarction
Summary
 Blood pressure monitoring
 NIBP
 IBP
 Central venous pressure monitoring
 Pulmonary artery pressure monitoring
 Mixed venous oxygen monitoring
 Cardiac output
QUESTIONS
1. WRITE ABOUT PRESSURE
TRANSDUCRE. 5MARKS
2. WRITE COMPLICATIONS OF SWAN-GANZ.
3MARKS
Thank you

Monitoring in ICU

  • 1.
    Clinical monitoring in theICU Dr. Abhijit Diwate (Associate Professor) Cardio-Vascular & Respiratory PT DVVPF College of Physiotherapy, Ahmednagar 414111
  • 2.
    Objectives  Blood pressuremonitoring  NIBP  IBP  Central venous pressure monitoring  Pulmonary artery pressure monitoring  Mixed venous oxygen monitoring  Cardiac output
  • 3.
    Why monitor BP? Alterations inherent  Provides data for interpretation/therapeutic decisions  Important for determining organ perfusion (MAP most important, except with the heart)
  • 4.
    Noninvasive Hemodynamic Monitoring Noninvasive BP  Heart Rate, pulses  Mental Status  Mottling (absent)  Skin Temperature  Capillary Refill  Urine Output
  • 5.
  • 6.
     CVP measuresthe filling pressure of the right ventricular (RV); it gives an estimate of the intravascular volume status and is an interplay of the: (1) circulating blood volume (2) venous tone and (3) right ventricular function.
  • 7.
    NORMAL CVP MEASUREMENTS  CVPmonitoring should normally show measurements as follows:  Mid Axilla: 0 - 8 mmHg  An isolated CVP reading is of limited value; a trend of readings is much more significant and should be viewed in conjunction with other parameters e.g. BP and urine output.
  • 8.
    sites A. Central linefrom peripheral site (antecubital fossa commonly selected) B. Femoral site C. External jugular site D. Subclavian site E. Internal jugular site  All have their own indications, contraindications, advantages & disadvantages
  • 9.
    Equipment  Sterile gloves Sterile gown and mask (optional)  Sterile prep solution  Local anesthetic  Syringes  Sterile flush solution  Suture material (might be included in the kit)  Dressing material  Manometer set (this may vary according to whether C.V.P. to be transduced or not )  500ml of0.9% Sodium Chloride. (500ml Sodium Chloride with 500 units heparin used in transduced circuits only)  Pressure bag (only used in transduced circuits)  Sedatives (if required)
  • 10.
    WATER MANOMETER:  Simple& inexpensive  Any piece of open IV tubing can be used  Specific problems include:  Placement of the catheter in the right ventricle  TR with a large reflux pressure wave  Giant ‘a’ waves from the atrium ( cannon waves, A-V dissociation & nodal rhythms) Each of these will lead to CVP measurements which may be misleading, & markedly different from the real prassure
  • 11.
    EQUIPMENT (a) a sterilebag of fluids (b) attached fluid administration set (c) an IV extension set (d) a manometer and (e) a stopcock a. b. c. d. e.
  • 12.
    PRESSURE TRANSDUCER:  An electronicsystem with fast response time & gives a more accurate wave representation  This enables maximum & minimum pressures to be identified as well as visualization of the wave form which may supply information about the presence, for example of tricuspid incompetence  Further more the mean pressure can be measured & this is usually the true CVP as it takes in to account the respiratory cycle
  • 13.
     Disadvantages:  Complexin setting up the system  Costly  Nursing staff need to be familiar with the system  There is always a risk of electronic problems (such as ‘baseline drift‘ or mechanical damping of the system by unnoticed air bubbles in the line or transducer dome
  • 14.
    INFORMATION FROM THECVP WAVEFORM  Besides the actual pressure measurement there is much information that can be gained from examining the waveforms
  • 15.
    WAVEFORMS IN CVP consistsof three upwards (a, c, & v waves) and two downward defections (x and y descents). 1. ‘a’ wave → by right atrial contraction and occurs just after the P wave on the ECG. 2. The ‘c’ wave → due to isovolumic ventricular contraction forcing the tricuspid valve to bulge upward into the RA 3. The pressure within the RA then decreases as the tricuspid valve is pulled away from the atrium during right ventricular ejection, forming the X descent. 4. The RA continues to fill during late ventricular systole, forming the V wave 5. The Y descent occurs when the tricuspid valve opens and blood from the RA empties rapidly into the RV during early diastole
  • 16.
    THE CVP WAVEFORM Reflects changes in right atrial pressure during the cardiac cycle
  • 17.
    Respiratory variation inCVP  The respiratory pattern in CVP can be used to predict fluid responsiveness  patients who have no inspiratory fall in CVP are on the flat part of their cardiac function curve and will not respond to fluids whereas patients who have an inspiratory fall in CVP are on the ascending part of the cardiac function curve and may or may not respond to fluids, depending how close they start to the plateau  Patients with an inspiratory fall in CVP are also more likely to have a fall in cardiac output with the application of PEEP
  • 18.
    Complications of centralvenous catheterization  Complications of central venous cannulation  Arterial puncture with hematoma  Arteriovenous fistula  Hemothorax  Chylothorax  Pneumothorax  Nerve injury Brachial plexus Stellate ganglion (Horner’s syndrome)  Air emboli  Catheter or wire shearing  Complications of catheter presence  Thrombosis, thromboembolism  Infection, sepsis, endocarditis  Arrhythmias  Hydrothorax
  • 19.
    REMOVAL OF CENTRALLINE  THIS IS AN ASEPTIC PROCEDURE  THE PATIENT SHOULD BE SUPINE WITH HEAD TILTED DOWN  ENSURE NO DRUGS ARE ATTACHED AND RUNNING VIA THE CENTRAL LINE  REMOVE DRESSING  CUT THE STITCHES  SLOWLY REMOVE THE CATHETER  IF THERE IS RESISTENCE THEN CALL FOR ASSISTANCE  APPLY DIGITAL PRESSURE WITH GAUZE UNTIL BLEEDING STOPS  DRESS WITH GAUZE AND CLEAR DRESSING EG TEGADERM
  • 20.
    PULMONARY ARTERY ANDPULMONARY CAPILLARY WEDGE PRESSURE MONITORING  The introduction of pulmonary artery catheter (PAC) in clinical medicine  one of the most popular and important advances in monitoring.  With this catheter:  PAP, PCWP & CVP can be measured easily  under most circumstances provides an accurate estimate of the diastolic filling (preload) of the left heart  Cardiac output determination using thermo-dilution technique is an equally important use of this catheter
  • 21.
    Indications For PAP& PCWP Monitoring A. Cardiac problems/surgery:  Poor LV function (EF<0.4; LVEDP> 18 mm Hg)  Recent MI  Pts with right heart failure  Procedures involving CPB  Complications of MI eg. MR, VSD, ventricular aneurysm.  Combined lesions eg. CAD+MR or CAD+AS  Complicated lesions eg. IHSS  Hemodynamically unstable pts requiring inotropes or IABP counterpulsation  Major procedures with large fluid shifts and/or blood loss in pts with CAD B. Non-cardiac situations:  Shock of any cause or MOF  Severe pulmonary disease , COPD , PHTN, or PE  Pts requiring high levels of PEEP  Bleomycin toxicity  Complicated surgical procedure  Massive trauma  Hepatic transplantation
  • 22.
    PA (Swan-Ganz) Catheterdescription  The standard 7F thermo-dilution pulmonary artery catheter consists of a single catheter 110 cm in length containing four lumina.  It is constructed of flexible, radio-opaque polyvinyl chloride.  10 cm increments are marked in black on the catheter beginning at the distal end.  At the distal end of the catheter is a latex balloon of 1.5 cc capacity.  When inflated, the balloon extends slightly beyond the tip of the catheter but does not obstruct it
  • 24.
  • 25.
    Types of PAcatheters 1.1. The thermo dilution catheter:The thermo dilution catheter:  is the one described above; using this catheter, thermo dilution cardiac output & other divided haemodynamic parameters may be measured 2.2. Pacing:Pacing:  Some PAC’s have the capacity to provide intra cardiac pacing
  • 26.
    3.3. Mixed venousoxygen saturation:Mixed venous oxygen saturation:  Special fiber-optic PAC can be used to monitor mixed venous oxygen saturation SVO2 continuously by the principle of absorption and reflectance of light through blood  The normal SVO2 is 75%normal SVO2 is 75% and a 5– 10 % increase or decrease is considered significant  A significant decrease in SVO2decrease in SVO2 may be due to: (a) a decrease in the cardiac output (b) increase in metabolic rate (c) decrease in arterial oxygen saturation.
  • 27.
    4.4. Ejection fractioncatheter :Ejection fraction catheter :  New-catheters with faster thermistor response times can be used to determine the right ventricular ejectionright ventricular ejection fraction in addition to the cardiac outputfraction in addition to the cardiac output 5.5. Continuous cardiac output measurement :Continuous cardiac output measurement :  Continuous cardiac output measuring PACs contain an integrated thermal filament at level of the RV  This filament is activated in a programmed sequence to provide small amounts of heat, which is then detected in the PA by a thermistor  The data by the device yields a rapidly updated, near continuous value for cardiac output
  • 32.
  • 33.
  • 34.
    Components of theMonitoring System  Bedside monitor – amplifier is located inside  The amplifier increases the size of signal  Transducer – changes the mechanical energy or pressures of pulse into electrical energy; should be level with the phlebostatic axis (intersecting lines from the 4th ICS,mid axillary line)
  • 35.
  • 36.
    Pulmonary Artery Pressure Monitoring Contraindications  AbsoluteAbsolute  Tricuspid or Pulmonary valve stenosis  RA or RV masses  Tetralogy of Fallot  RelativeRelative  Severe arrhythmias  Coagulopathy  Newly inserted pacemaker wires
  • 37.
    Complications of Swan-Ganz A.Complications of cannulationComplications of cannulation  Arterial puncture (carotid, subclavia)  Haematoma, haemothorax  Pleural effusion iv) Nerve injury (brachial plexus, stellate ganglion)  Emboli (air, catheter insertion) B. Complications of catheter insertionComplications of catheter insertion  Cardiac perforation  Cardiac dysrhythmia , heart block  Knotting  Tricuspid, pulmonary valve injury C. Complications of catheter presenceComplications of catheter presence  Thrombosis, thromboembolism  Infection, endocarditis, sepsis  Pulmonary artery rupture iv) Pulmonary infarction
  • 38.
    Summary  Blood pressuremonitoring  NIBP  IBP  Central venous pressure monitoring  Pulmonary artery pressure monitoring  Mixed venous oxygen monitoring  Cardiac output
  • 39.
    QUESTIONS 1. WRITE ABOUTPRESSURE TRANSDUCRE. 5MARKS 2. WRITE COMPLICATIONS OF SWAN-GANZ. 3MARKS
  • 40.

Editor's Notes

  • #17 A wave: right atrial contraction (P wave on the ECG)If the A wave is elevated the patient may have right ventricular failure or tricuspid stenosis. C wave: tricuspid valve closure (follows QRS complex on the ECG). V wave: pressure generated to the right atrium during ventricular contraction, despite the tricuspid valve being closed (latter part of the T wave on the ECG)